Director, Global Market Access and Pricing, Immunology

Role Summary

Location: Cambridge, MA.

The Global Market Access and Pricing (GMAP) lead for Immunology will be responsible for access analytics and championing the one-voice market access perspective for pipeline assets throughout the development timeline. This includes providing market access input to support indication selection, clinical development plans at all stages, broader payer data generation efforts, forecasts, and governance meetings, while also developing top-line value messaging to support pricing benchmarks. This is a highly collaborative role that requires a strong cross-functional approach, working with partners across New Product Planning, Clinical, Medical, HEVA, Regulatory, and HVT, as well as relevant country teams, to realize the pricing and access potential of the portfolio. The role also entails improving early market access capabilities and planning across key assets in the pipeline through play-to-win behaviors.

Responsibilities

• Leads the assessment of various internal assets and potential target indications, in collaboration with the therapeutic global cross-functional partners
• Leads the development of the access and pricing strategy of internal assets, based on relevant scenarios developed in collaboration with New Product Planning
• Responsible for the timely development a clear Early Market Access Roadmap for all assets under scope to ensure the organization has the right level of understanding and preparedness to support decision making and market preparation
• Responsible for the timely execution of all core activities pertaining to the following:
  • Foundational knowledge of disease and payer unmet needs (through conducting secondary and primary payer research where relevant)
  • Early market access success factors / risks identification
  • Fact-based early potential assessments (with price/access assumptions for forecasting) and scenario development
  • Informed market access input to clinical development plan & pivotal trial design
  • Early market access plan
  • Early payer value proposition
  • Payer evidence plan and IEGP support, in partnership with HEVA, to ensure it supports the Payer Value proposition
• As part of the GPT and early commercialization team:
  • Contributes to the formulation and execution of the asset(s) strategy and ensure key payer/ market access considerations are made explicit and are addressed as appropriate (target patient population, clinical endpoints, comparator, etc)
  • Provides the relevant support for governance meetings (ie, TARC, DWG, IDCC, SPM, etc)
• Coordinates the relevant Market Access GLocal subteams, ensuring relevant input and engagement from priority markets
• Maintain a high level of knowledge with regards to the scientific, clinical, strategic pricing and commercial developments relevant to the assets under scope
• Develop and maintain a robust understanding of relevant pricing and reimbursement criteria used by payers in key markets to make informed decisions about payer strategy, plans and tactics
• Improves early market access capabilities across the pipeline through methodology & standard improvement in areas such as value assessment, strategic pricing, robust and early insights generation, scenario development, risk management

Skills

• CORE BEHAVIORAL COMPETENCIES: Push to go beyond the level we have operated until now; be intolerant to mediocracy, believe we can and must do better
• CORE BEHAVIORAL COMPETENCIES: Put the interest of the organization ahead of your own or those of your team; enable decision making at appropriate level
• CORE BEHAVIORAL COMPETENCIES: Act in the interest of our patients and customers; bring an external perspective into decisions
• CORE BEHAVIORAL COMPETENCIES: Take action and don’t wait to be told what to do; make bold and impactful decisions

Qualifications

• Minimum 7 years of relevant professional experience with an accomplished track record in market access
• Strong interest for clinical drug development / the science and shaping early strategies in a continuously evolving environment
• Strong analytical skills, including pricing, with ability to translate clinical information and messages into clear payer access strategies / recommendations
• Flexibility and demonstrated ability to work across multiple projects and priorities as well as across diverse and complex payer archetypes in the US and ex-US geographies
• Outstanding written and oral communication skills, including the ability to write and deliver presentations to professionals at all levels within Sanofi in a straightforward way
• Strong leadership and demonstrated relationship building; ability to work well in a cross-functional team and build coalition
• Understanding of the evolution of the market access landscape and implications for the business
• Demonstrated business acumen, analytical and financial skills to evaluate investment strategies, and comfortable with product forecast and P&L, quantitative skills

Education

• Master’s degree in science, business, or related discipline